GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $264,000 | 0.0% | 6,066 | 0.0% | 0.03% | +17.4% |
| Q1 2022 | $264,000 | -1.1% | 6,066 | +0.0% | 0.02% | +4.5% |
| Q4 2021 | $267,000 | +7.2% | 6,065 | -13.2% | 0.02% | -12.0% |
| Q1 2021 | $249,000 | -5.0% | 6,986 | -1.8% | 0.02% | -16.7% |
| Q4 2020 | $262,000 | +8.3% | 7,111 | +38.1% | 0.03% | -21.1% |
| Q4 2019 | $242,000 | +5.7% | 5,151 | -3.8% | 0.04% | -2.6% |
| Q3 2019 | $229,000 | +7.0% | 5,355 | 0.0% | 0.04% | +5.4% |
| Q2 2019 | $214,000 | -4.5% | 5,355 | 0.0% | 0.04% | -7.5% |
| Q1 2019 | $224,000 | – | 5,355 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |